New to The Street and NRx Pharmaceuticals Launch 12-Part Media Series

New to The Street, a prominent multi-platform financial news show, announced a 12-part media partnership with NRx Pharmaceuticals, Inc., a biopharmaceutical firm focused on life-saving therapies for severe mental health conditions. This collaboration will include monthly televised interviews with NRx CEO Dr. Jonathan Javitt, sharing updates on biotech innovations.

The partnership will extend across television, digital media, and outdoor platforms. It plans to produce content for networks like ABC, NBC, and CBS, alongside TV commercials and billboards in high-traffic areas such as Times Square.

The series will commence later this month on Fox Business and Bloomberg Television, aiming to reach over 245 million homes across the U.S. and the Middle East. Additionally, episodes will be available on New to The Street's YouTube channel, supported by extensive media amplification.